Surmodics, a provider of medical device and in vitro diagnostic technologies to the healthcare industry, announced the launch of a single-coat formulation of its most advanced hydrophilic medical device coating, Serene solutions. Specifically formulated for individual medical device applications, Serene single-coat (SC) solutions allow manufacturers to leverage their legacy coating process to apply this surface treatment.
Surmodics’ Serene coatings help device manufacturers meet the challenge of achieving the right balance of lubricity (reduction in friction) and durability for intravascular products. Surmodics continues with significant advances in coating formulations, achieving low friction and low-particulate generation with the latest formulation of Serene SC coating, that meet manufacturer’s current processes to accelerate development and meet customer needs.
Serene coatings can be applied to a broad variety of substrates to achieve optimal performance for devices used in the following clinical areas:
- Coronary – Reduce friction and improve device pushability and trackability through tortuous anatomy, and crossability of coronary lesions;
- Peripheral – Easily coat differing device diameters and lengths for optimal navigability in long, diffused, diseased vessels;
- Neurovascular – Rely on low friction coatings to negotiate small, tortuous neurovascular pathways where pushability is limited; and
- Structural Heart – Effectively manage the device deliverability and repositioning requirements specific to structural heart procedures.
“With regulatory attention increasingly focused on lowering particulates, we’ve experienced quick adoption of Serene coatings among manufacturers already equipped for a two-coat process,” said Gary Maharaj, president and CEO. “Serene SC solutions will broaden the range of medical device companies able to benefit from the unmatched lubricity and durability this product family provides.”
Hydrophilic coatings continue to be a critical design input to help medical devices navigate tortuous vascular pathways. Hydrophilic coatings reduce risk of damage to blood vessel walls and allow physicians to reach distal treatment sites for procedures for improved therapeutic outcomes.